Age- and Gender-Based Trends in Schizophrenia Onset
Investigators evaluated data collected for a population-based study of nearly 1.5 million adults that was conducted at seven sites across Australia.
Investigators evaluated data collected for a population-based study of nearly 1.5 million adults that was conducted at seven sites across Australia.
Investigators sought to further understand the link between cognitive dysfunction and disturbed sleep in patients with schizophrenia and determine future sleep interventions to improve functioning and disability.
Facial anger recognition was significantly associated with schizophrenia polygenic risk score.
Data for this analysis were sourced from the Danish High Risk and Resilience Study. Participants were identified through the Danish Civil Registration System and Danish Psychiatric Central Research Register.
In this study, mental disorders were determined using data from the Danish Psychiatric Central Research Register and general medical conditions from the Danish National Patient Register.
Among fully vaccinated adults, diagnosis of a psychiatric disorder linked to increased incidence of SARS-CoV-2 breakthrough infection.
Some patients with schizophrenia may experience residual symptoms when treated with antipsychotics, due in part to their side effects. This analysis aims to examine both short-term improvement and residual symptoms of prescribed medication.
Outpatients with schizophrenia who were seeking treatment for cannabis use disorder were recruited between 2017 and 2020 at the Center for Addiction and Mental Health in Canada.
Researchers estimated the 10- and 30-year risk for cardiovascular disease in patients with serious mental illness.
A panel of 15 experts and stakeholders reviewed findings of a systematic literature search and discussed the impact of the COVID-19 pandemic on mental health care, clinical practice, and management of individuals with schizophrenia and BP-I.